104.61
price up icon2.53%   2.58
after-market Dopo l'orario di chiusura: 104.80 0.19 +0.18%
loading
Precedente Chiudi:
$102.03
Aprire:
$105.575
Volume 24 ore:
1.90M
Relative Volume:
0.86
Capitalizzazione di mercato:
$16.56B
Reddito:
$4.34B
Utile/perdita netta:
$-965.00M
Rapporto P/E:
-17.23
EPS:
-6.07
Flusso di cassa netto:
$869.00M
1 W Prestazione:
+7.89%
1M Prestazione:
+15.45%
6M Prestazione:
-22.37%
1 anno Prestazione:
-9.51%
Intervallo 1D:
Value
$104.32
$105.62
Intervallo di 1 settimana:
Value
$92.25
$105.62
Portata 52W:
Value
$68.70
$156.66

Illumina Inc Stock (ILMN) Company Profile

Name
Nome
Illumina Inc
Name
Telefono
(858) 202-4500
Name
Indirizzo
5200 ILLUMINA WAY, SAN DIEGO, CA
Name
Dipendente
8,970
Name
Cinguettio
@illumina
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
ILMN's Discussions on Twitter

Confronta ILMN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
ILMN
Illumina Inc
104.61 16.15B 4.34B -965.00M 869.00M -6.07
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
466.71 161.42B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
197.89 135.99B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
540.68 42.78B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
119.47 33.01B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
194.24 31.85B 15.50B 1.33B 2.16B 7.34

Illumina Inc Stock (ILMN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-11 Downgrade Scotiabank Sector Outperform → Sector Perform
2025-03-04 Reiterato Citigroup Neutral
2025-02-28 Downgrade HSBC Securities Buy → Hold
2025-02-10 Downgrade Barclays Equal Weight → Underweight
2025-02-07 Downgrade TD Cowen Buy → Hold
2024-12-11 Downgrade Citigroup Buy → Neutral
2024-11-12 Ripresa Morgan Stanley Equal-Weight
2024-10-17 Aggiornamento HSBC Securities Hold → Buy
2024-08-28 Aggiornamento Argus Hold → Buy
2024-08-16 Aggiornamento Daiwa Securities Neutral → Buy
2024-08-14 Aggiornamento Barclays Underweight → Equal Weight
2024-08-14 Aggiornamento TD Cowen Hold → Buy
2024-07-10 Aggiornamento Citigroup Neutral → Buy
2024-06-03 Ripresa Jefferies Hold
2024-01-16 Downgrade HSBC Securities Buy → Hold
2024-01-04 Downgrade TD Cowen Outperform → Market Perform
2023-12-18 Aggiornamento Scotiabank Sector Perform → Sector Outperform
2023-12-15 Aggiornamento Bernstein Underperform → Mkt Perform
2023-12-14 Iniziato Guggenheim Buy
2023-12-14 Iniziato Stephens Overweight
2023-12-13 Iniziato Wolfe Research Outperform
2023-12-12 Downgrade BofA Securities Neutral → Underperform
2023-12-11 Aggiornamento Citigroup Sell → Neutral
2023-11-10 Downgrade Canaccord Genuity Buy → Hold
2023-09-28 Iniziato Bernstein Underperform
2023-07-05 Ripresa JP Morgan Neutral
2023-01-25 Downgrade Argus Buy → Hold
2023-01-05 Iniziato Scotiabank Sector Perform
2022-12-12 Downgrade Citigroup Neutral → Sell
2022-12-07 Iniziato RBC Capital Mkts Outperform
2022-10-04 Aggiornamento SVB Leerink Mkt Perform → Outperform
2022-09-28 Aggiornamento Evercore ISI In-line → Outperform
2022-08-25 Iniziato Credit Suisse Neutral
2022-07-13 Downgrade Barclays Equal Weight → Underweight
2022-01-18 Aggiornamento Stifel Hold → Buy
2022-01-11 Aggiornamento Barclays Underweight → Equal Weight
2022-01-07 Aggiornamento BofA Securities Underperform → Neutral
2022-01-06 Ripresa Morgan Stanley Equal-Weight
2022-01-06 Ripresa Piper Sandler Overweight
2021-10-15 Ripresa Cowen Outperform
2021-08-19 Downgrade SVB Leerink Outperform → Mkt Perform
2021-06-01 Aggiornamento Evercore ISI Underperform → In-line
2021-03-31 Downgrade Atlantic Equities Overweight → Neutral
2021-03-31 Aggiornamento Canaccord Genuity Hold → Buy
2021-03-03 Iniziato Barclays Underweight
2020-12-22 Aggiornamento Piper Sandler Neutral → Overweight
2020-12-17 Aggiornamento BTIG Research Neutral → Buy
2020-10-13 Downgrade Guggenheim Buy → Neutral
2020-09-30 Iniziato Atlantic Equities Overweight
2020-09-29 Downgrade Wolfe Research Outperform → Peer Perform
2020-09-22 Downgrade Stifel Buy → Hold
2020-09-22 Downgrade UBS Buy → Neutral
2020-09-21 Aggiornamento Guggenheim Neutral → Buy
2020-09-21 Downgrade JP Morgan Overweight → Neutral
2020-09-09 Iniziato Morgan Stanley Equal-Weight
2020-08-07 Downgrade Evercore ISI In-line → Underperform
2020-08-07 Downgrade Piper Sandler Overweight → Neutral
2020-07-07 Downgrade Guggenheim Buy → Neutral
2020-04-24 Downgrade Citigroup Buy → Neutral
2020-04-21 Downgrade Robert W. Baird Outperform → Neutral
2020-01-08 Iniziato Wells Fargo Underweight
2020-01-07 Iniziato Citigroup Buy
2020-01-02 Downgrade Evercore ISI Outperform → In-line
2019-11-15 Iniziato Stifel Buy
2019-10-25 Iniziato Guggenheim Buy
Mostra tutto

Illumina Inc Borsa (ILMN) Ultime notizie

pulisher
03:00 AM

Is Illumina Inc. a good long term investmentBreakthrough stock performance - Autocar Professional

03:00 AM
pulisher
07:42 AM

ILLUMINA, INC. (ILMN) - MSN

07:42 AM
pulisher
07:19 AM

Whole Genome Sequencing Market Booming, to Reach US$ 8,608 - openPR.com

07:19 AM
pulisher
07:04 AM

Multi-Omics Market Attracts Big Players, to Hit $33.25B by 2033 | - openPR.com

07:04 AM
pulisher
05:35 AM

What analysts say about Illumina Inc. stockOutstanding growth strategies - Autocar Professional

05:35 AM
pulisher
Jul 22, 2025

What drives Illumina Inc. stock priceBreakneck growth rates - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Lobbying Update: $410,000 of ILLUMINA INC. lobbying was just disclosed - Quiver Quantitative

Jul 22, 2025
pulisher
Jul 22, 2025

DNA Test Kits Market Booming with Consumer Genomics Demand - openPR.com

Jul 22, 2025
pulisher
Jul 22, 2025

Bioinformatics Services Market Surge Backed by Genomics - openPR.com

Jul 22, 2025
pulisher
Jul 22, 2025

Illumina Inc. Stock Analysis and ForecastUnstoppable profit momentum - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Illumina India Wins the Top GCC Award at the 2025 GCC Workplace Awards - ThePrint

Jul 22, 2025
pulisher
Jul 21, 2025

Standard BioTools Schedules Second Quarter Earnings Conference Call on August 11, 2025 - GlobeNewswire Inc.

Jul 21, 2025
pulisher
Jul 18, 2025

Published on: 2025-07-19 09:23:06 - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

Killer acquisitions: what the future holds post-Illumina — Consumer Competition Market Blog - Faculteit Rechtsgeleerdheid en Criminologische Wetenschappen

Jul 18, 2025
pulisher
Jul 18, 2025

Favorable Government Support Fuels Germany's Biotech Innovation and Commercialization: Market to Surpass USD 94 Billion by 2034 Led by QIAGEN, Thermo Fisher Scientific, Illumina and Roche - Yahoo Finance

Jul 18, 2025
pulisher
Jul 17, 2025

Illumina’s SWOT analysis: genomics giant faces headwinds as stock outlook shifts - Investing.com

Jul 17, 2025
pulisher
Jul 17, 2025

March 2026 Options Now Available For Illumina (ILMN) - Nasdaq

Jul 17, 2025
pulisher
Jul 17, 2025

Illumina Stock: What Went Wrong And Why It's Best To Stay Away - 富途牛牛

Jul 17, 2025
pulisher
Jul 16, 2025

Single-Cell Omics Market Growth in Future Scope 2025-2032 |10x - openPR.com

Jul 16, 2025
pulisher
Jul 15, 2025

DNA Microarray Market Size, Industry Growth Insights Report - openPR.com

Jul 15, 2025
pulisher
Jul 14, 2025

Bioinformatics Market Set to Witness Significant Growth by 2033 - openPR.com

Jul 14, 2025
pulisher
Jul 13, 2025

How To Trade (ILMN) - news.stocktradersdaily.com

Jul 13, 2025
pulisher
Jul 12, 2025

Illumina: Higher Profit Margin Despite GRAIL Divestiture And Macroeconomic Headwinds - Seeking Alpha

Jul 12, 2025
pulisher
Jul 11, 2025

Illumina stock downgraded at Scotiabank (ILMN:NASDAQ) - Seeking Alpha

Jul 11, 2025
pulisher
Jul 11, 2025

Scotiabank Downgrades Illumina to Sector Perform From Sector Outperform, Reduces Price Target to $125 From $164 - MarketScreener

Jul 11, 2025
pulisher
Jul 10, 2025

Illumina to Announce Second Quarter 2025 Financial Results on Thursday, July 31, 2025 - 富途牛牛

Jul 10, 2025
pulisher
Jul 10, 2025

Industry Focus eBook: Infectious diseases - News-Medical

Jul 10, 2025
pulisher
Jul 10, 2025

Illumina named to TIME's World's Most Sustainable Companies list for the second consecutive year - PR Newswire

Jul 10, 2025
pulisher
Jul 10, 2025

Illumina Achieves Double Recognition: #2 Most Sustainable US Company and Best Workplace Excellence - Stock Titan

Jul 10, 2025
pulisher
Jul 09, 2025

Illumina, Inc.'s (NASDAQ:ILMN) Shareholders Might Be Looking For Exit - simplywall.st

Jul 09, 2025
pulisher
Jul 09, 2025

Illumina Shares Fall After Citigroup Downgrade - MarketScreener

Jul 09, 2025
pulisher
Jul 09, 2025

Why Illumina (ILMN) Shares Are Falling Today - Yahoo Finance

Jul 09, 2025
pulisher
Jul 09, 2025

Illumina: Citigroup downgrades to 'Sell' Rating, The Target Price is $80 - AInvest

Jul 09, 2025
pulisher
Jul 09, 2025

Illumina stock down as Citi cuts on recent rally (ILMN:NASDAQ) - Seeking Alpha

Jul 09, 2025
pulisher
Jul 09, 2025

Illumina Shares Slip After Citi Issues Bearish Rating Ahead of Earnings - MSN

Jul 09, 2025
pulisher
Jul 09, 2025

Illumina Inc. Stock Outperforms Competitors On Strong Trading Day - 富途牛牛

Jul 09, 2025

Illumina Inc Azioni (ILMN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
diagnostics_research WAT
$295.63
price up icon 2.84%
$137.82
price down icon 1.50%
diagnostics_research DGX
$170.48
price down icon 4.35%
diagnostics_research LH
$250.51
price down icon 0.62%
diagnostics_research MTD
$1,257.20
price up icon 3.14%
diagnostics_research IQV
$194.24
price up icon 3.66%
Capitalizzazione:     |  Volume (24 ore):